The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because ...
HHS and the Drug Enforcement Administration have finalized a rule that expands telemedicine prescribing of buprenorphine for opioid use disorder, while also proposing a new special registration ...
FDA Pushes for New Buprenorphine Labeling The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because of the rise of high-potency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback